254 related articles for article (PubMed ID: 25897902)
1. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs.
Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
Int J Cardiol; 2015 Jun; 189():188-93. PubMed ID: 25897902
[TBL] [Abstract][Full Text] [Related]
2. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.
Zhan JK; Tan P; Wang YJ; Wang Y; He JY; Tang ZY; Huang W; Liu YS
Cardiovasc Diabetol; 2014 Nov; 13():153. PubMed ID: 25407893
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway.
Zhan JK; Wang YJ; Wang Y; Tang ZY; Tan P; Huang W; Liu YS
Exp Cell Res; 2014 May; 323(2):352-8. PubMed ID: 24607448
[TBL] [Abstract][Full Text] [Related]
4. The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells.
Zhan JK; Wang YJ; Wang Y; Wang S; Tan P; Huang W; Liu YS
Can J Cardiol; 2014 May; 30(5):568-75. PubMed ID: 24518659
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
7. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.
Liao XB; Zhang ZY; Yuan K; Liu Y; Feng X; Cui RR; Hu YR; Yuan ZS; Gu L; Li SJ; Mao DA; Lu Q; Zhou XM; de Jesus Perez VA; Yuan LQ
Endocrinology; 2013 Sep; 154(9):3344-52. PubMed ID: 23798596
[TBL] [Abstract][Full Text] [Related]
8. Cortistatin inhibits calcification of vascular smooth muscle cells by depressing osteoblastic differentiation and endoplasmic reticulum stress.
Liu Y; Lin F; Fu Y; Chen W; Liu W; Chi J; Zhang X; Yin X
Amino Acids; 2016 Nov; 48(11):2671-2681. PubMed ID: 27480534
[TBL] [Abstract][Full Text] [Related]
9. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression.
Liu GY; Liang QH; Cui RR; Liu Y; Wu SS; Shan PF; Yuan LQ; Liao EY
Endocrinology; 2014 Feb; 155(2):558-67. PubMed ID: 24248461
[TBL] [Abstract][Full Text] [Related]
10. Globular adiponectin inhibits osteoblastic differentiation of vascular smooth muscle cells through the PI3K/AKT and Wnt/β-catenin pathway.
Zhou Y; Wei LL; Zhang RP; Han CW; Cao Y
J Mol Histol; 2021 Oct; 52(5):1067-1080. PubMed ID: 34398360
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells Calcification.
Lee J; Hong SW; Kim MJ; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
Diabetes Metab J; 2024 Jan; 48(1):83-96. PubMed ID: 38173373
[TBL] [Abstract][Full Text] [Related]
12. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells.
Shan PF; Lu Y; Cui RR; Jiang Y; Yuan LQ; Liao EY
PLoS One; 2011 Mar; 6(3):e17938. PubMed ID: 21437254
[TBL] [Abstract][Full Text] [Related]
13. Vinpocetine Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells.
Ma YY; Sun L; Chen XJ; Wang N; Yi PF; Song M; Zhang B; Wang YZ; Liang QH
PLoS One; 2016; 11(9):e0162295. PubMed ID: 27589055
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide attenuates the osteoblastic differentiation of MC3T3‑E1 cells by modulating AMPK/mTOR signaling.
Hu XK; Yin XH; Zhang HQ; Guo CF; Tang MX
Mol Med Rep; 2016 Oct; 14(4):3662-8. PubMed ID: 27600753
[TBL] [Abstract][Full Text] [Related]
15. Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media.
Sutra T; Morena M; Bargnoux AS; Caporiccio B; Canaud B; Cristol JP
Free Radic Res; 2008 Sep; 42(9):789-97. PubMed ID: 19051077
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro.
Cao F; Wang S; Cao X; Liu X; Fu K; Hao P; Liu J
J Pharm Pharmacol; 2017 Dec; 69(12):1802-1816. PubMed ID: 28980322
[TBL] [Abstract][Full Text] [Related]
17. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment.
Wen P; Cao H; Fang L; Ye H; Zhou Y; Jiang L; Su W; Xu H; He W; Dai C; Yang J
Exp Cell Res; 2014 Apr; 322(2):302-12. PubMed ID: 24486760
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
19. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.
Zhao H; Wang L; Wei R; Xiu D; Tao M; Ke J; Liu Y; Yang J; Hong T
Diabetes Obes Metab; 2014 Sep; 16(9):850-60. PubMed ID: 24641303
[TBL] [Abstract][Full Text] [Related]
20. Puerarin attenuates calcification of vascular smooth muscle cells.
Lu Q; Xiang DX; Yuan HY; Xiao Y; Yuan LQ; Li HB
Am J Chin Med; 2014; 42(2):337-47. PubMed ID: 24707866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
